Table 4 Cumulative effects of rs4848320-T and rs1110839-G on lung cancer and non-small cell lung cancer susceptibility
Variant | Controls (%) (593) | Lung cancer | Non-small cell lung cancer | ||||
|---|---|---|---|---|---|---|---|
Cases (%) (434) | ORa (95% CI) | P value | Cases (%) (331) | ORa (95% CI) | P value | ||
No. of alleles | |||||||
 0 (ref) | 232 (39.1) | 168 (38.7) | 1.00 (ref) |  | 129 (39.0) | 1.00 (ref) |  |
 1 | 174 (29.3) | 115 (26.5) | 0.893 (0.654–1.218) | 0.474 | 85 (25.7) | 0.871 (0.619–1.225) | 0.427 |
 2 | 132 (22.3) | 112 (25.8) | 1.167 (0.846–1.612) | 0.346 | 88 (26.6) | 1.207 (0.852–1.710) | 0.291 |
 3–4 | 55 (9.3) | 39 (9.0) | 0.985 (0.622–1.560) | 0.948 | 29 (8.8) | 0.947 (0.572–1.569) | 0.833 |
Trend |  |  | Pb = 0.893 |  |  | Pb = 0.964 |  |
 0 | 232 (39.1) | 168 (38.7) | 1.00 (ref) |  | 129 (39.0) | 1.00 (ref) |  |
 1–4 | 361 (60.9) | 266 (61.3) | 1.007 (0.780–1.301) | 0.955 | 202 (61.0) | 1.005 (0.761–1.328) | 0.971 |